Upholding patient safety and data integrity in clinical development
Accelagen’s expert, multidisciplinary team takes a patient-centric approach to ensure studies maintain safety and data integrity from start to finish.
- Contribution and Leadership of Drug Development Solutions
- Key Expert Liasion and Engagement
- Clinical Trial Design and Implementation Strategies
- Clinical Trial Safety Monitoring and Evaluation
- Safety Reporting in accordance with Local and International Regulations
- Utilising state-of-the-art Safety and Pharmacovigilance Database technologies to enhance adverse event monitoring and management
- Ongoing drug safety profile evaluation
- Lead up to date risk evaluation and mitigation strategies
How we work
.svg){kind=icon}
Patient-first safety monitoring and management
Accelagen’s expert approach to clinical trial safety planning, monitoring and management ensures participants' safety throughout the study and minimises risk to patient care. Includes individual case safety report collection and medical review.
Comprehensive safety data and reporting
Clear, considered safety narratives and regular reporting delivers detailed adverse event knowledge, ready for regulatory submissions. Includes development of safety data exchange agreements, risk management plans and ongoing literature reviews and monitoring.
Medical and safety management
case studies
.webp)
